kabutan

ZERIA PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 32%

Thu Feb 5, 2026 4:00 pm JST Earnings

4559 ZERIA PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

ZERIA PHARMACEUTICAL CO.,LTD. <4559> [TSE Prime] announced its financial results after the market closed on February 5th (16:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) dropped 31.7% from the same period last year to 7.28 billion yen. Progress toward the full-year plan of 12.0 billion yen was 60.7%, also falling below the five-year average of 98.3%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to surge 2.2 times that of the same period last year, reaching 4.71 billion yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit increased 70.7% from the same period last year, reaching 4.63 billion yen. The operating profit margin rose from 16.9% in the same period last year to 20.4%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 57,919 9,490 9,444 8,423 191.1 110.9 Feb 1, 2024 J-GAAP
Apr - Dec, 2024 64,773 10,246 10,661 8,226 186.6 83.0 Feb 5, 2025 J-GAAP
Apr - Dec, 2025 64,077 8,566 7,286 5,554 126.0 60.7 Feb 5, 2026 J-GAAP
YoY -1.1% -16.4% -31.7% -32.5% -32.5%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 44,889 5,738 4,891 3,875 87.9 24 May 8, 2025 J-GAAP
Oct - Mar, 2025 Guidance 50,040 8,359 9,344 7,763 176.1 24 Nov 5, 2025 J-GAAP
YoY +11.5% +45.7% +91.0% +100.3% +100.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 75,725 9,621 8,513 7,731 175.4 44 May 9, 2024 J-GAAP
Mar, 2025 87,311 12,197 12,840 9,936 225.4 47 May 8, 2025 J-GAAP
Mar, 2026 Guidance 90,000 12,000 12,000 9,500 215.5 48 May 8, 2025 J-GAAP
YoY +3.1% -1.6% -6.5% -4.4% -4.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 22,351 3,787 2,712 2,165 49.1 16.9 Feb 5, 2025 J-GAAP
Jan - Mar, 2025 22,538 1,951 2,179 1,710 38.8 8.7 May 8, 2025 J-GAAP
Apr - Jun, 2025 19,489 1,520 1,662 1,090 24.8 7.8 Aug 5, 2025 J-GAAP
Jul - Sep, 2025 20,471 2,121 994 647 14.7 10.4 Nov 5, 2025 J-GAAP
Oct - Dec, 2025 24,117 4,925 4,630 3,817 86.6 20.4 Feb 5, 2026 J-GAAP
YoY +7.9% +30.1% +70.7% +76.3% +76.3%

Related Articles